Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Roberts

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 12, 2008
Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding modeM Raymond V Finlay, David G Acton, David M Andrews, et al.
Internal Medicine Journal|April 3, 2018
Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical settingBelinda Lee, Ben Tran, Arthur L Hsu, et al.
Gastro Hep Advances|January 29, 2025
A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver FailureNatalie L Y Ngu, Edward Saxby, Thomas Worland, et al.
Journal of Patient-Reported Outcomes|August 28, 2024
APPROACH e-PROM system: a user-centered development and evaluation of an electronic patient-reported outcomes measurement system for management of coronary artery diseaseAndrew Roberts, Eleanor Benterud, Maria J Santana, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesityMichael H Block, Scott Boyer, Wayne Brailsford, et al.
Science Translational Medicine|June 15, 2018
Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsMalcolm Anderson, David M Andrews, Andy J Barker, et al.
Trials|July 21, 2023
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trialsSarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, et al.
The Lancet. Infectious Diseases|March 22, 2026
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trialsSanjeev M Bijukchhe, Natalie G Marchevsky, Freddie Kibengo, et al.
The American Journal of Sports Medicine|January 20, 2023
A Randomized Trial of Autologous Chondrocyte Implantation Versus Alternative Forms of Surgical Cartilage Management in Patients With a Failed Primary Treatment for Chondral or Osteochondral Defects in the KneeMartyn Snow, Lee Middleton, Samir Mehta, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|July 12, 2008
Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding modeM Raymond V Finlay, David G Acton, David M Andrews, et al.
Internal Medicine Journal|April 3, 2018
Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical settingBelinda Lee, Ben Tran, Arthur L Hsu, et al.
Gastro Hep Advances|January 29, 2025
A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver FailureNatalie L Y Ngu, Edward Saxby, Thomas Worland, et al.
Journal of Patient-Reported Outcomes|August 28, 2024
APPROACH e-PROM system: a user-centered development and evaluation of an electronic patient-reported outcomes measurement system for management of coronary artery diseaseAndrew Roberts, Eleanor Benterud, Maria J Santana, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesityMichael H Block, Scott Boyer, Wayne Brailsford, et al.
Science Translational Medicine|June 15, 2018
Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsMalcolm Anderson, David M Andrews, Andy J Barker, et al.
Trials|July 21, 2023
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trialsSarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, et al.
The Lancet. Infectious Diseases|March 22, 2026
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trialsSanjeev M Bijukchhe, Natalie G Marchevsky, Freddie Kibengo, et al.
The American Journal of Sports Medicine|January 20, 2023
A Randomized Trial of Autologous Chondrocyte Implantation Versus Alternative Forms of Surgical Cartilage Management in Patients With a Failed Primary Treatment for Chondral or Osteochondral Defects in the KneeMartyn Snow, Lee Middleton, Samir Mehta, et al.
Pageof 15